Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2024-02-27

FDA Approved: LEVETIRACETAM — Original Application (B. Braun Medical Inc.)

View source ↗

Summary

FDA approved the generic levetiracetam from B. Braun Medical Inc. under an original ANDA.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • LEVETIRACETAM (levetiracetam)

Snippet

ORIG AP for LEVETIRACETAM (LEVETIRACETAM)